Cover Image

Association of systolic blood pressure variability with cognitive decline in type 2 diabetes: A post hoc analysis of a randomized clinical trial

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Junmin Chen, Xuan Zhao, Huidan Liu, Kan Wang, Xiaoli Xu, Siyu Wang, Mian Li, Ruizhi Zheng, Libin Zhou, Yufang Bi, Yu Xu
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of Diabetes
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Longitudinal exposure to non‐ HDL ‐C and cardiovascular events, all‐cause mortality in type 2 diabetes: A post hoc analysis of the ACCORD trial
by: Yueyue Wang, et al.
Published: (2026)

Effect of insulin sensitivity, insulin secretion, and beta cell function on the remission of type 2 diabetes: A post hoc analysis of the IDEATE trial
by: Xianglin Wu, et al.
Published: (2025)

Effects of Intensive Systolic Blood Pressure Control on Kidney Outcomes in Patients With and Without CKD : A Post Hoc Analysis of SPRINT and ACCORD ‐ BP Trials
by: Xiaoli Xu, et al.
Published: (2025)

Effect of semaglutide on primary prevention of diabetic kidney disease in people with type 2 diabetes: A post hoc analysis of the SUSTAIN 6 randomized controlled trial
by: Jingyu Wang, et al.
Published: (2024)

Cardiovascular outcomes under hypothetical blood‐pressure‐lowering intervention in type 2 diabetes: A target trial emulation
by: Xue Tian, et al.
Published: (2026)

Semaglutide withdrawal in adults with type 1 diabetes on pump therapy: A post‐hoc analysis from a double‐blinded randomized controlled trial
by: Melissa‐Rosina Pasqua, et al.
Published: (2025)

Efficacy and safety of Efsubaglutide Alfa in “overrun” patients in the SUPER2 trial: A post‐hoc analysis for comprehensive evaluation
by: Weiping Jia, et al.
Published: (2025)

Differences in imeglimin response in subgroups of patients with type 2 diabetes stratified by data‐driven cluster analysis: A post‐hoc analysis of imeglimin clinical trial data
by: Katsuhiko Hagi, et al.
Published: (2024)

Gastrointestinal symptoms in patients receiving imeglimin in combination with metformin: A post‐hoc analysis of imeglimin clinical trial data
by: Jumpei Ito, et al.
Published: (2024)

Survodutide, a glucagon receptor/glucagon‐like peptide‐1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo‐controlled, dose‐finding, phase 2 trial
by: Carel W. le Roux, et al.
Published: (2024)

Impact of sotagliflozin on glomerular hyperfiltration in people with type 1 diabetes: A post hoc analysis of the inTandem3 trial
by: Amrit Pathak, et al.
Published: (2025)

Sodium–glucose cotransporter 2 inhibition and injection burden in mild diabetic macular edema: An exploratory post hoc analysis of the COMET trial
by: Yoko Takatsuna, et al.
Published: (2026)

Time spent in glycaemic control with sustained body weight reduction with tirzepatide: A post hoc analysis of the SURPASS clinical trial programme
by: Brandon K. Bergman, et al.
Published: (2025)

Socioeconomic and mental health inequalities in global burden of type 2 diabetes: Evidence from the Global Burden of Disease Study 2021
by: Mingling Chen, et al.
Published: (2025)

Cofrogliptin once every 2 weeks as add‐on therapy to metformin versus daily linagliptin in patients with type 2 diabetes in China: A randomized, double‐blind, non‐inferiority trial
by: Qian Ren, et al.
Published: (2024)

Effects of reducing sedentary behaviour on renal glucose uptake during insulin stimulation: A post‐hoc analysis of a 6‐month randomized controlled trial
by: Eleni Rebelos, et al.
Published: (2025)

Variability in HbA1c and the risk of major clinical outcomes in type 2 diabetes with chronic kidney disease: Post hoc analysis from the CREDENCE trial
by: Ying Zhu, et al.
Published: (2025)

Erythropoiesis and estimated fluid volume regulation following initiation of ipragliflozin treatment in patients with type 2 diabetes mellitus and chronic kidney disease: A post‐hoc analysis of the PROCEED trial
by: Tatsuya Maruhashi, et al.
Published: (2024)

Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial
by: Melissa‐Rosina Pasqua, et al.
Published: (2025)

Relationship between the progression of diabetic polyneuropathy and impaired circadian blood pressure variability
by: Dai Yamagami, et al.
Published: (2024)

Effects of GLP ‐1 receptor agonists on cognitive function in patients with type 2 diabetes: A systematic review and meta‐analysis based on randomized controlled trials
by: Suxin Wan, et al.
Published: (2025)

Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes
by: Shujun Zhang, et al.
Published: (2024)

Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double‐blind, randomized, placebo‐controlled trial
by: Minji Sohn, et al.
Published: (2024)

The effect of HbA1c variability on the efficacy of intensive blood pressure control in patients with type 2 diabetes
by: Xiaopu Wang, et al.
Published: (2024)

Evaluation of a novel eating disorder prevention programme (Australian diabetes body project) for young women with type 1 diabetes in a clinic setting: A randomized controlled trial protocol
by: Neisha D'Silva, et al.
Published: (2026)

A Mendelian randomization study on the causal association of circulating cytokines with diabetic nephropathy
by: Yiming Xu, et al.
Published: (2025)

Application of the integrated data platform combined with dietary management for adults with diabetes: A prospective randomized controlled trial
by: Xiyu Liu, et al.
Published: (2024)

Sodium‐glucose co‐transporter 2 inhibitors reduce the intravitreal anti‐ VEGF treatment necessity in eyes with early diabetic macular oedema: A post‐hoc analysis focusing on the fellow eye of the COMET trial
by: Tomoaki Tatsumi, et al.
Published: (2025)

Retrospective analysis of influences of sacubitril/valsartan in patients with diabetes with poorly controlled blood pressure in Japan
by: Shun Ito, et al.
Published: (2025)

Comparative efficacy and safety of weekly tirzepatide versus weekly insulin in type 2 diabetes: A network meta‐analysis of randomized clinical trials
by: Hazem Ayesh, et al.
Published: (2024)

Associations of glycaemia‐related risk factors with dementia and cognitive decline in individuals with type 2 diabetes: A systematic review and meta‐analysis
by: Mahtab Tabesh, et al.
Published: (2025)

Health‐related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT ‐ ONE
by: Nele Steenackers, et al.
Published: (2024)

Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post‐hoc analysis of the EMMY trial
by: Caren Sourij, et al.
Published: (2024)

The process of blood coagulation in individuals with diabetes mellitus
by: Nabila Harsa Ahmad, et al.
Published: (2024)

Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan‐O‐AP and LixiLan‐L‐CN trials
by: Wenying Yang, et al.
Published: (2024)

Combination of retagliptin and henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, active‐controlled, phase 3 trial
by: Yao Wang, et al.
Published: (2024)

Evaluation of efficacy of iGlarLixi versus IDegAsp using derived time‐in‐ranges in Chinese adults with Type 2 diabetes: A post hoc analysis of the Soli‐D study
by: Juan Liu, et al.
Published: (2025)

Decreased fatty liver index with tirzepatide treatment in Japanese patients with type 2 diabetes: A SURPASS J‐mono post hoc analysis
by: Masato Yoneda, et al.
Published: (2025)

Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant‐level analysis of the ONWARDS 1–5 trials
by: Peter Rossing, et al.
Published: (2025)

Type 2 diabetes, glycaemic traits, structural brain capacity and cognitive function: A Mendelian randomization analysis
by: Manjun Luo, et al.
Published: (2024)